Bill Text: FL H0873 | 2010 | Regular Session | Introduced

---

Bill Title: Controlled Substances

Spectrum: Partisan Bill (Republican 1-0)

Status: (Failed) 2010-04-30 - Died in Committee on Health Care Regulation Policy (HFPC) [H0873 Detail]

Download: Florida-2010-H0873-Introduced.html

---

HB 873

1	A bill to be entitled
2	An act relating to controlled substances; amending s.
3	893.03, F.S.; revising the list of controlled substances
4	in Schedules I, II, III, IV, and V; providing that the
5	salts, isomers, or salts of isomers are included within
6	certain substances listed in Schedule III; providing an
7	effective date.
8
9	Be It Enacted by the Legislature of the State of Florida:
10
11	Section 1. Paragraph (c) of subsection (1), paragraphs (a)
12	and (b) of subsection (2), paragraph (a) of subsection (3),
13	subsection (4), and paragraph (b) of subsection (5) of section
14	893.03, Florida Statutes, are amended to read:
15	893.03 Standards and schedules.-The substances enumerated
16	in this section are controlled by this chapter. The controlled
17	substances listed or to be listed in Schedules I, II, III, IV,
18	and V are included by whatever official, common, usual,
19	chemical, or trade name designated. The provisions of this
20	section shall not be construed to include within any of the
21	schedules contained in this section any excluded drugs listed
22	within the purview of 21 C.F.R. s. 1308.22, styled "Excluded
23	Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical
24	Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted
25	Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt
26	Anabolic Steroid Products."
27	(1) SCHEDULE I.-A substance in Schedule I has a high
28	potential for abuse and has no currently accepted medical use in
29	treatment in the United States and in its use under medical
30	supervision does not meet accepted safety standards. The
31	following substances are controlled in Schedule I:
32	(c) Unless specifically excepted or unless listed in
33	another schedule, any material, compound, mixture, or
34	preparation which contains any quantity of the following
35	hallucinogenic substances or which contains any of their salts,
36	isomers, and salts of isomers, whenever the existence of such
37	salts, isomers, and salts of isomers is possible within the
38	specific chemical designation:
39	1. Alpha-ethyltryptamine.
40	2. 2-Amino-4-methyl-5-phenyl-2-oxazoline (4-
41	methylaminorex).
42	3. 2-Amino-5-phenyl-2-oxazoline (Aminorex).
43	4. 4-Bromo-2,5-dimethoxyamphetamine.
44	5. 4-Bromo-2, 5-dimethoxyphenethylamine.
45	6. Bufotenine.
46	7. Cannabis.
47	8. Cathinone.
48	9. Diethyltryptamine.
49	10. 2,5-Dimethoxyamphetamine.
50	11. 2,5-Dimethoxy-4-ethylamphetamine (DOET).
51	12. Dimethyltryptamine.
52	13. N-Ethyl-1-phenylcyclohexylamine (PCE) (Ethylamine
53	analog of phencyclidine).
54	14. N-Ethyl-3-piperidyl benzilate.
55	15. N-ethylamphetamine.
56	16. Fenethylline.
57	17. N-Hydroxy-3,4-methylenedioxyamphetamine.
58	18. Ibogaine.
59	19. Lysergic acid diethylamide (LSD).
60	20. Mescaline.
61	21. Methcathinone.
62	22. 5-Methoxy-3,4-methylenedioxyamphetamine.
63	23. 4-methoxyamphetamine.
64	24. 4-methoxymethamphetamine.
65	25. 4-Methyl-2,5-dimethoxyamphetamine.
66	26. 3,4-Methylenedioxy-N-ethylamphetamine.
67	27. 3,4-Methylenedioxyamphetamine.
68	28. N-Methyl-3-piperidyl benzilate.
69	29. N,N-dimethylamphetamine.
70	30. Parahexyl.
71	31. Peyote.
72	32. N-(1-Phenylcyclohexyl)-pyrrolidine (PCPY) (Pyrrolidine
73	analog of phencyclidine).
74	33. Psilocybin.
75	34. Psilocyn.
76	35. Salvia divinorum, except for any drug product approved
77	by the United States Food and Drug Administration which contains
78	Salvia divinorum or its isomers, esters, ethers, salts, and
79	salts of isomers, esters, and ethers, whenever the existence of
80	such isomers, esters, ethers, and salts is possible within the
81	specific chemical designation.
82	36. Salvinorin A, except for any drug product approved by
83	the United States Food and Drug Administration which contains
84	Salvinorin A or its isomers, esters, ethers, salts, and salts of
85	isomers, esters, and ethers, whenever the existence of such
86	isomers, esters, ethers, and salts is possible within the
87	specific chemical designation.
88	37. Tetrahydrocannabinols.
89	38. 1-[1-(2-Thienyl)-cyclohexyl]-piperidine (TCP)
90	(Thiophene analog of phencyclidine).
91	39. 3,4,5-Trimethoxyamphetamine.
92	40. Alpha-methyltryptamine.
93	41. 1-(1-Phenylcyclohexyl) pyrrolidine.
94	42. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine.
95	43. 5-Methoxy-N, N-diisopropyltryptamine.
96	44. N-Benzylpiperazine.
97	(2) SCHEDULE II.-A substance in Schedule II has a high
98	potential for abuse and has a currently accepted but severely
99	restricted medical use in treatment in the United States, and
100	abuse of the substance may lead to severe psychological or
101	physical dependence. The following substances are controlled in
102	Schedule II:
103	(a) Unless specifically excepted or unless listed in
104	another schedule, any of the following substances, whether
105	produced directly or indirectly by extraction from substances of
106	vegetable origin or independently by means of chemical
107	synthesis:
108	1. Opium and any salt, compound, derivative, or
109	preparation of opium, except nalmefene or isoquinoline alkaloids
110	of opium, including, but not limited to the following:
111	a. Raw opium.
112	b. Opium extracts.
113	c. Opium fluid extracts.
114	d. Powdered opium.
115	e. Granulated opium.
116	f. Tincture of opium.
117	g. Codeine.
118	h. Ethylmorphine.
119	i. Etorphine hydrochloride.
120	j. Hydrocodone.
121	k. Hydromorphone.
122	l. Levo-alphacetylmethadol (also known as levo-alpha-
123	acetylmethadol, levomethadyl acetate, or LAAM).
124	m. Metopon (methyldihydromorphinone).
125	n. Morphine.
126	o. Oxycodone.
127	p. Oxymorphone.
128	q. Thebaine.
129	r. Dihydroetorphine.
130	2. Any salt, compound, derivative, or preparation of a
131	substance which is chemically equivalent to or identical with
132	any of the substances referred to in subparagraph 1., except
133	that these substances shall not include the isoquinoline
134	alkaloids of opium.
135	3. Any part of the plant of the species Papaver
136	somniferum, L.
137	4. Cocaine or ecgonine, including any of their
138	stereoisomers, and any salt, compound, derivative, or
139	preparation of cocaine or ecgonine.
140	(b) Unless specifically excepted or unless listed in
141	another schedule, any of the following substances, including
142	their isomers, esters, ethers, salts, and salts of isomers,
143	esters, and ethers, whenever the existence of such isomers,
144	esters, ethers, and salts is possible within the specific
145	chemical designation:
146	1. Alfentanil.
147	2. Alphaprodine.
148	3. Anileridine.
149	4. Bezitramide.
150	5. Bulk propoxyphene (nondosage forms).
151	6. Carfentanil.
152	7. Dihydrocodeine.
153	8. Diphenoxylate.
154	9. Fentanyl.
155	10. Isomethadone.
156	11. Levomethorphan.
157	12. Levorphanol.
158	13. Metazocine.
159	14. Methadone.
160	15. Methadone-Intermediate,4-cyano-2-
161	dimethylamino-4,4-diphenylbutane.
162	16. Moramide-Intermediate,2-methyl-
163	3-morpholoino-1,1-diphenylpropane-carboxylic acid.
164	17. Nabilone.
165	18. Pethidine (meperidine).
166	19. Pethidine-Intermediate-A,4-cyano-1-
167	methyl-4-phenylpiperidine.
168	20. Pethidine-Intermediate-B,ethyl-4-
169	phenylpiperidine-4-carboxylate.
170	21. Pethidine-Intermediate-C,1-methyl-4- phenylpiperidine-
171	4-carboxylic acid.
172	22. Phenazocine.
173	23. Phencyclidine.
174	24. 1-Phenylcyclohexylamine.
175	25. Piminodine.
176	26. 1-Piperidinocyclohexanecarbonitrile.
177	27. Racemethorphan.
178	28. Racemorphan.
179	29. Sufentanil.
180	30. Lisdexamfetamine.
181	31. Remifentanil.
182	(3) SCHEDULE III.-A substance in Schedule III has a
183	potential for abuse less than the substances contained in
184	Schedules I and II and has a currently accepted medical use in
185	treatment in the United States, and abuse of the substance may
186	lead to moderate or low physical dependence or high
187	psychological dependence or, in the case of anabolic steroids,
188	may lead to physical damage. The following substances are
189	controlled in Schedule III:
190	(a) Unless specifically excepted or unless listed in
191	another schedule, any material, compound, mixture, or
192	preparation which contains any quantity of the following
193	substances having a depressant or stimulant effect on the
194	nervous system, including its salts, isomers, and salts of
195	isomers whenever the existence of such salts, isomers, or salts
196	of isomers is possible within the specific chemical designation:
197	1. Any substance which contains any quantity of a
198	derivative of barbituric acid, including thiobarbituric acid, or
199	any salt of a derivative of barbituric acid or thiobarbituric
200	acid, including, but not limited to, butabarbital and
201	butalbital.
202	2. Benzphetamine.
203	3. Chlorhexadol.
204	4. Chlorphentermine.
205	5. Clortermine.
206	6. Lysergic acid.
207	7. Lysergic acid amide.
208	8. Methyprylon.
209	9. Phendimetrazine.
210	10. Sulfondiethylmethane.
211	11. Sulfonethylmethane.
212	12. Sulfonmethane.
213	13. Tiletamine and zolazepam or any salt thereof.
214	14. Embutramide.
215	(4) SCHEDULE IV.-A substance in Schedule IV has a low
216	potential for abuse relative to the substances in Schedule III
217	and has a currently accepted medical use in treatment in the
218	United States, and abuse of the substance may lead to limited
219	physical or psychological dependence relative to the substances
220	in Schedule III. Unless specifically excepted or unless listed
221	in another schedule, any material, compound, mixture, or
222	preparation which contains any quantity of the following
223	substances, including its salts, isomers, and salts of isomers
224	whenever the existence of such salts, isomers, and salts of
225	isomers is possible within the specific chemical designation,
226	are controlled in Schedule IV:
227	(a) Alprazolam.
228	(b) Barbital.
229	(c) Bromazepam.
230	(d) Camazepam.
231	(e) Cathine.
232	(f) Chloral betaine.
233	(g) Chloral hydrate.
234	(h) Chlordiazepoxide.
235	(i) Clobazam.
236	(j) Clonazepam.
237	(k) Clorazepate.
238	(l) Clotiazepam.
239	(m) Cloxazolam.
240	(n) Delorazepam.
241	(o) Propoxyphene (dosage forms).
242	(p) Diazepam.
243	(q) Diethylpropion.
244	(r) Estazolam.
245	(s) Ethchlorvynol.
246	(t) Ethinamate.
247	(u) Ethyl loflazepate.
248	(v) Fencamfamin.
249	(w) Fenfluramine.
250	(x) Fenproporex.
251	(y) Fludiazepam.
252	(z) Flurazepam.
253	(aa) Halazepam.
254	(bb) Haloxazolam.
255	(cc) Ketazolam.
256	(dd) Loprazolam.
257	(ee) Lorazepam.
258	(ff) Lormetazepam.
259	(gg) Mazindol.
260	(hh) Mebutamate.
261	(ii) Medazepam.
262	(jj) Mefenorex.
263	(kk) Meprobamate.
264	(ll) Methohexital.
265	(mm) Methylphenobarbital.
266	(nn) Midazolam.
267	(oo) Nimetazepam.
268	(pp) Nitrazepam.
269	(qq) Nordiazepam.
270	(rr) Oxazepam.
271	(ss) Oxazolam.
272	(tt) Paraldehyde.
273	(uu) Pemoline.
274	(vv) Pentazocine.
275	(ww) Phenobarbital.
276	(xx) Phentermine.
277	(yy) Pinazepam.
278	(zz) Pipradrol.
279	(aaa) Prazepam.
280	(bbb) Propylhexedrine, excluding any patent or proprietary
281	preparation containing propylhexedrine, unless otherwise
282	provided by federal law.
283	(ccc) Quazepam.
284	(ddd) Tetrazepam.
285	(eee) SPA[(-)-1 dimethylamino-1, 2 diphenylethane].
286	(fff) Temazepam.
287	(ggg) Triazolam.
288	(hhh) Not more than 1 milligram of difenoxin and not less
289	than 25 micrograms of atropine sulfate per dosage unit.
290	(iii) Butorphanol tartrate.
291	(jjj) Carisoprodol.
292	(kkk) Zopiclone.
293	(lll) Zaleplon.
294	(mmm) Zolpidem.
295	(nnn) Modafinil.
296	(ooo) Petrichloral.
297	(ppp) Sibutramine.
298	(qqq) Dichloralphenazone.
299	(5) SCHEDULE V.-A substance, compound, mixture, or
300	preparation of a substance in Schedule V has a low potential for
301	abuse relative to the substances in Schedule IV and has a
302	currently accepted medical use in treatment in the United
303	States, and abuse of such compound, mixture, or preparation may
304	lead to limited physical or psychological dependence relative to
305	the substances in Schedule IV.
306	(b) Narcotic drugs. Unless specifically excepted or unless
307	listed in another schedule, any material, compound, mixture, or
308	preparation containing any of the following narcotic drugs and
309	their salts:
310	1. Buprenorphine.
311	2. Pregabalin.
312	3. Not more than 0.5 milligrams of difenoxin and not less
313	than 25 micrograms of atrophine sulfate per dosage unit.
314	Section 2. This act shall take effect July 1, 2010.

CODING: Words stricken are deletions; words underlined are additions.